[[{“value”:”
In the first ever human clinical trial, a mRNA cancer vaccination developed at the University of Florida successfully reprogrammed patients’ immune system to attack glioblastoma – the most aggressive and deadly brain tumor. The results of four adult patients were similar to those of 10 dogs with brain tumors, whose owners had approved their participation. […]
The post Cancer Vaccine Triggers Fierce immune Response to Fight Malignant Brain Tumors appeared first on Good News Network.
“}]] An mRNA cancer vaccine developed at the University of Florida was first to successfully reprogrammed patients ‘ immune systems to fiercely combat glioblastoma, the most aggressive and fatal brain tumor, in a human clinical trial. Four adult patients ‘ outcomes matched those of ten brain tumor-positive puppy dog patients whose owners approved of their participation.
On Good News Network, the article Cancer Vaccine Causes a Fierce Immune Response to Treat Malignant Brain Tumors in Human Patients second appeared.
